The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
about
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care CascadeConceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up.Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, CaliforniaEighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmissionThe cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation ProgramClinical impact of treatment timing for chronic hepatitis C infection: a decision modelCan HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast MichiganEvaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level.The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysisHepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.Cost-Effectiveness of the Hepatitis C Self-Management Program.Improving Hepatitis C Identification: Technology Alone Is Not the Answer.Considerations for the Development of a Substance-Related Care and Prevention Continuum Model.Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers.Retention in buprenorphine treatment is associated with improved HCV care outcomes.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.Care for people with hepatitis C in provincial and territorial prisons.The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.[Health-Related Quality of Life in patients with hepatitis C treated with dual and triple therapy].Beyond signal functions in global obstetric care: Using a clinical cascade to measure emergency obstetric readiness.Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. Petersburg.Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation.Increasing hepatitis C screening in a large integrated health system: science and policy in concertRapid testing for hepatitis C does not infer current infectionBeyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in AustraliaA Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service FacilitiesInterventions to Address Basic Resource Needs in Kaiser Permanente: A Care Continuum and an Outcomes Wheel
P2860
Q28547529-7BDA6EC0-5F5E-44B8-8187-CD9A0C9691F1Q30238798-42067E55-9EE1-4781-A107-C0573E5C94DEQ30873859-C4C0413B-DC8C-458B-8102-54BDF7C97C3BQ33578932-CB8BAD77-A367-480E-AF15-48A8C8BF3BF6Q33629561-B1C052DD-BCC9-4E78-BB57-A3BC73E50D4FQ33795852-AB1B10E9-FEDB-4900-AB30-9101820E4240Q33825807-4E118693-D3B1-4367-8389-889D959A21C2Q35572125-44B5BC1F-3DAF-4764-92A5-C6D4A049A3B7Q35690302-E9A2F82D-6083-4C2E-B089-216A71FE8C2EQ35752660-D6D9D63B-1096-4A92-8110-6297ED2B3833Q35889164-3B46CE22-E54A-4CD8-8E43-F944F4F1952CQ35998417-B518C7F1-2088-41F5-9A48-E3E3ACA5CDEEQ36090175-9DE417B2-93E2-4BCE-A4F1-6032166CBB77Q36104175-70F92CF1-0F19-41AD-BB31-994936C960C4Q36783216-652763C4-6D2D-4119-AB7E-ED3A6AE192CAQ36849533-49532B8A-DDC7-4C08-AF0C-6716BA198959Q36858873-8C786DD2-74F9-407D-8477-EBEDF7CB814BQ37084628-CDB4A111-29F6-427B-B531-E030B06B9CA4Q37692611-02F6CF0D-858D-474E-9D4D-9286E3F9BC97Q39749160-95FEE554-3B63-47F5-BBE6-2A1EF380BD8FQ40047408-45C93B7D-4804-4EC0-8FE4-0E8D75962B73Q40097145-BFCBC0BE-E58E-408B-938B-6D6932183BE6Q40104694-7F2421D1-5AE3-4B1E-84B4-E0D658DD8731Q40317993-D7778F34-6803-486D-B9C6-B8E301F98EE8Q41919051-6843E667-2D0F-4690-9330-F2F44F5C63DEQ45325293-E8AB8AB5-799F-49AA-82A6-03E735D52A12Q47548170-F7FD2B3F-0516-478B-ADC3-9074B2733618Q47550695-BA82F487-19CE-4633-B771-8B966BE7E08AQ47554747-36585920-58FF-42A3-9F67-43E0DE3BDBDCQ48506117-40FCBB76-741B-41B5-B25C-23DD7E893C1BQ50270442-6FC5524B-E566-46EA-84AE-F43AAE0DF48AQ51748448-1A474390-2B5E-44E5-A17C-1601FB20CA5BQ52312138-5CC27DE6-C691-4F44-A682-CAAF8E3C1B75Q55429477-B10DB068-B2FB-4A39-A6B0-49693229D761Q56654945-E90D3455-EFAE-436C-8607-C3027309C750Q56890548-38AAD9E9-7497-45C9-9793-1F217AFED228Q57169238-B0D51890-70ED-428C-92D0-C457F40A14FEQ57826499-8E8151CC-4EBE-408B-B73B-8C958168F7B2Q58698529-D876E11A-F9AB-4B57-96B9-4D4C9E152D3D
P2860
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@ast
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@en
type
label
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@ast
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@en
prefLabel
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@ast
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@en
P2093
P2860
P50
P1433
P1476
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
@en
P2093
Arthur Y Kim
Benjamin P Linas
Bruce R Schackman
Devra M Barter
Sabrina A Assoumou
P2860
P304
P356
10.1371/JOURNAL.PONE.0097317
P407
P577
2014-05-19T00:00:00Z